As of 2024-12-14, the Relative Valuation of Combigene AB (COMBI.ST) is (53.58) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 2.70 SEK, the upside of Combigene AB based on Relative Valuation is -2084.6%.
The range of the Relative Valuation is (42.94) - (56.33) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.3x - 31.1x | 30.8x |
| Forward P/E multiples | 21.2x - 30.5x | 27.3x |
| Fair Price | (42.94) - (56.33) | (53.58) |
| Upside | -1690.4% - -2186.4% | -2084.6% |
| Date | P/E |
| 2024-12-04 | -1.40 |
| 2024-12-03 | -1.41 |
| 2024-12-02 | -1.40 |
| 2024-11-29 | -1.43 |
| 2024-11-28 | -1.43 |
| 2024-11-27 | -1.45 |
| 2024-11-26 | -1.39 |
| 2024-11-25 | -1.28 |
| 2024-11-22 | -1.39 |
| 2024-11-21 | -1.40 |
| 2024-11-20 | -1.34 |
| 2024-11-19 | -1.39 |
| 2024-11-18 | -1.42 |
| 2024-11-15 | -1.52 |
| 2024-11-14 | -1.49 |
| 2024-11-13 | -1.40 |
| 2024-11-12 | -1.40 |
| 2024-11-11 | -1.30 |
| 2024-11-08 | -1.44 |
| 2024-11-07 | -1.44 |
| 2024-11-06 | -1.44 |
| 2024-11-05 | -1.39 |
| 2024-11-04 | -1.36 |
| 2024-11-01 | -1.13 |
| 2024-10-31 | -0.80 |
| 2024-10-30 | -0.92 |
| 2024-10-29 | -0.95 |
| 2024-10-28 | -0.93 |
| 2024-10-25 | -1.26 |
| 2024-10-24 | -1.36 |
| 2024-10-23 | -1.32 |
| 2024-10-22 | -1.27 |
| 2024-10-21 | -1.29 |
| 2024-10-18 | -1.33 |
| 2024-10-17 | -1.32 |
| 2024-10-16 | -1.36 |
| 2024-10-15 | -1.31 |
| 2024-10-14 | -1.38 |
| 2024-10-11 | -1.44 |
| 2024-10-10 | -1.43 |
| 2024-10-09 | -1.36 |
| 2024-10-08 | -1.34 |
| 2024-10-07 | -1.40 |
| 2024-10-04 | -1.38 |
| 2024-10-03 | -1.38 |
| 2024-10-02 | -1.44 |
| 2024-10-01 | -1.45 |
| 2024-09-30 | -1.52 |
| 2024-09-27 | -1.32 |
| 2024-09-26 | -1.32 |